Huge congratulations to our very own Prof. Werring ⁦UCL Stroke Research⁩ on his election to the Academy of Medical Sciences ⁦Academy of Medical Sciences⁩ ⁦UCL Brain Sciences⁩ ⁦UCL Queen Square Institute of Neurology⁩ ⁦UCLH⁩ ucl.ac.uk/news/2025/may/…

Our paper on managing post stroke fatigue is just published! Small feasibility study but some signel around reducing fatigue, increasing activity and improving mood. doi.org/10.1177/026921…

Fantastic talk from ⁦Gargi Banerjee⁩ at #EAN2025 on central amyloid angiopathy. Great to hear how role of inflammation is opening up diagnostics and even treatment

📢 We are seeking abstracts for #ELASF2026 in three categories: 1. Scientific 2. Service development 3. Lived experience More information 👉 bit.ly/3SUDbPg #LifeAfterStroke  #StrokeResearch  #StrokeBestPractice #StrokeLivedExperience

Collaboration on the optimal timing of anticoagulation after ischaemic stroke and atrial fibrillation: a systematic review and prospective individual participant data meta-analysis of randomised controlled trials (CATALYST) - The Lancet thelancet.com/journals/lance…

Read Prof David Werring’s commentary in The Lancet Neurology Rapid blood pressure lowering after acute intracerebral haemorrhage: time is brain, again - The Lancet Neurology thelancet.com/journals/laneu…

Collaboration on the optimal timing of anticoagulation after ischaemic stroke and atrial fibrillation: a systematic review and prospective individual participant data meta-analysis of randomised controlled trials (CATALYST) - The Lancet thelancet.com/journals/lance…

🎉 Huge congratulations to Gargi Banerjee (MRC Prion Unit at UCL Institute of Prion Diseases) on receiving a £2m MRC Clinician Scientist Fellowship! Her research will apply prion biology to diseases caused by the amyloid-beta protein to advance our understanding of potential transmission routes. 👉

Extremely Proud! ❤️🧿❤️

New UCL-led research published in The Lancet shows starting blood thinners within 4 days of a stroke is safe & cuts risk of another stroke by 30% for people with atrial fibrillation (an irregular heartbeat). UCL Stroke Research UCL Queen Square Institute of Neurology Prof Hakim Dehbi UCL Comprehensive Clinical Trials Unit buff.ly/F719i8L

This is a forum in which researchers and clinicians are given the opportunity to talk to each other about questions they have on aspects of neurorehabilitation and may inspire more clinicians to get involved in research. FREE REGISTRATION - ALL WELCOME onlinestore.ucl.ac.uk/conferences-an…

Please RT and please help! Audrey Bowen Dr Jenny Preston MBE Charlie Chung Prof Katerina Hilari Stroke Research Stroke Association

ICYMI: Collaboration on the optimal timing of anticoagulation after ischaemic stroke and atrial fibrillation: a systematic review and prospective individual participant data meta-analysis of randomised controlled trials (CATALYST) hubs.li/Q03v__D-0

The Lancet Very happy to see this in print, the result of 8 years of collaboration between the RCT:s on this topic. The final result of the individual patient data systematic analysis showed that the total was larger than the parts; a demonstration of the power of evidence based principles

My deepest thanks to my supervisors, mentors, colleagues, family, and friends for their invaluable support and guidance! First generation PhD here ☺️

Congratulations Hatice Ozkan - brilliant researcher and most importantly one of the most authentic and kind person you could meet #risingstar Stroke Association British & Irish Association of Stroke Physicians UCL Stroke Research

Many congratulations Hatice Ozkan !

📢 Submit your scientific abstract for #ELASF2026 in Stockholm We are looking for completed or ongoing research focused on improving life after stroke, rehab, secondary prevention, long-term support etc. 🗓️ Deadline: 7 Oct 2025 👉 bit.ly/3SUDbPg #LifeAfterStroke

📢 Call for abstracts: #ELASF2026 Share your work on life after stroke with our international stroke community. Now accepting submissions in: 1. Scientific research and Service development (by 7 October 2025) 2. Lived experience (by 8 Aug 2025) 🔗 bit.ly/3SUDbPg

UCLH has recruited the first participant in the UK to a study looking at a new investigational drug for patients with a condition affecting the blood vessels in the brain called cerebral amyloid angiopathy (CAA).   Find out more: buff.ly/Yuly8jI @uclhresearch